Resilient Pharmaceuticals, Inc design mark 50165260
"Design mark 50165260" is a figurative mark owned by Resilient Pharmaceuticals, Inc., filed at the USPTO on October 16, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since October 16, 2026
- Filed
- October 16, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50165260
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 1 class
Who owns Resilient Pharmaceuticals, Inc design mark 50165260
The owner and representative on file with the office.
Owner
Resilient Pharmaceuticals, Inc.
Lake Forest, United States
Representative
Karen K. Won
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
What the mark covers
The products and services Resilient Pharmaceuticals, Inc design mark 50165260 is filed for, grouped by Nice class.
Pharmaceutical preparations, namely, prescription psychotropics; Psychotropic preparations for the treatment of psychiatric and psychological diseases and disorders; Psychotherapeutic preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions affecting mood, thought, behavior, and perception; Pharmaceutical preparations for the treatment and management of psychiatric, psychological, and neurological disorders; Therapeutic agents for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury; Medicaments to help assist with treatment and management of psychiatric, psychological, and neurological disorders.
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About Resilient Pharmaceuticals, Inc design mark 50165260
Who owns the trademark "Design mark 50165260"?
The USPTO trademark "Design mark 50165260" (application 50165260) is owned by Resilient Pharmaceuticals, Inc.
What is the status of "Design mark 50165260"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull Resilient Pharmaceuticals, Inc design mark 50165260 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a149f6-8809-745a-8ff5-ad7e4b811a0d
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a149f6-8809-745a-8ff5-ad7e4b811a0d",
"object": "trademark",
"mark_text": "[Design Mark]",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50165260",
"filing_date": "2026-10-16",
"nice_classes": [
5
],
"owners": [
{
"name": "Resilient Pharmaceuticals, Inc.",
"entity_id": null
}
]
}